NantOmics to Present Data on Using GPS Cancer Quantitative Proteomic Analysis of Class III B-Tubulin (TUBB3) to Predict Survival in Gastric Cancer Patients Randomized to Docetaxel at the American Society of Clinical Oncology (ASCO) 2017 Annual Meeting

Our Review Board

Our content is carefully reviewed by experienced professionals to ensure accuracy and relevance.

• Qualified Experts: Each article is assessed by specialists with field-specific knowledge.
• Up-to-date Insights: We incorporate the latest research, trends, and standards.
• Commitment to Quality: Reviewers ensure clarity, correctness, and completeness.

Look for the expert-reviewed label to read content you can trust.